Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Related Articles by Review for PubMed (Select 23498565)

1.

Lacosamide-induced valproic acid toxicity.

Jones GL, Popli GS, Silvia MT.

Pediatr Neurol. 2013 Apr;48(4):308-10. doi: 10.1016/j.pediatrneurol.2012.12.039.

PMID:
23498565
2.

Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.

Rigamonti A, Lauria G, Grimod G, Bianchi G, Salmaggi A.

J Clin Neurosci. 2014 Apr;21(4):690-1. doi: 10.1016/j.jocn.2013.04.033. Epub 2013 Oct 8. Review.

PMID:
24119342
3.

Valproate-induced hyperammonemic encephalopathy.

Verrotti A, Trotta D, Morgese G, Chiarelli F.

Metab Brain Dis. 2002 Dec;17(4):367-73. Review.

PMID:
12602513
4.

Valproate-associated hyperammonemic encephalopathy.

Wadzinski J, Franks R, Roane D, Bayard M.

J Am Board Fam Med. 2007 Sep-Oct;20(5):499-502. Review.

5.

Adverse drug reactions induced by valproic acid.

Nanau RM, Neuman MG.

Clin Biochem. 2013 Oct;46(15):1323-38. doi: 10.1016/j.clinbiochem.2013.06.012. Epub 2013 Jun 20. Review.

PMID:
23792104
6.

Valproate-induced hyperammonemic encephalopathy.

Segura-Bruna N, Rodriguez-Campello A, Puente V, Roquer J.

Acta Neurol Scand. 2006 Jul;114(1):1-7. Review.

PMID:
16774619
7.

Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy.

Mock CM, Schwetschenau KH.

Am J Health Syst Pharm. 2012 Jan 1;69(1):35-9. doi: 10.2146/ajhp110049. Review.

PMID:
22180549
8.

Lacosamide as adjunctive therapy for partial-onset epileptic seizures: a review of the clinical and economic literature.

Simoens S.

Curr Med Res Opin. 2011 Jul;27(7):1329-38. doi: 10.1185/03007995.2011.582863. Epub 2011 May 12. Review.

PMID:
21561394
9.

The efficacy of divalproex for partial epilepsies.

Smith MC.

Psychopharmacol Bull. 2003;37 Suppl 2:54-66. Review.

PMID:
15021861
10.

Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures.

Ben-Menachem E.

Drugs Today (Barc). 2008 Jan;44(1):35-40. doi: 10.1358/dot.2008.44.1.1178468. Review.

PMID:
18301802
11.

Carnitine in the treatment of valproic acid-induced toxicity.

Lheureux PE, Hantson P.

Clin Toxicol (Phila). 2009 Feb;47(2):101-11. doi: 10.1080/15563650902752376. Review.

PMID:
19280426
12.

Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide.

Becerra JL, Ojeda J, Corredera E, Ruiz Giménez J.

CNS Drugs. 2011 Dec 5;25 Suppl 1:3-16. doi: 10.2165/1159572-S0-000000000-00000. Review.

PMID:
22141347
13.

Oral valproic acid for epilepsy--long-term experience in therapy and side effects.

Gerstner T, Bell N, König S.

Expert Opin Pharmacother. 2008 Feb;9(2):285-92. doi: 10.1517/14656566.9.2.285 . Review.

PMID:
18201150
14.

[A case of valproate-associated hyperammonemia with chronic hepatitis C].

Fukushima M, Kotoh K, Enjoji M, Nakamuta M, Nawata H, Aishima S.

Nihon Shokakibyo Gakkai Zasshi. 2005 Jan;102(1):42-7. Review. Japanese. No abstract available.

PMID:
15682815
15.

[Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].

Fassi G, Igoa A, Liste OA.

Vertex. 2008 Nov-Dec;19(82):371-7. Review. Spanish.

PMID:
19424520
16.

Hyperammonemia due to valproic acid in the psychiatric setting.

Carr RB, Shrewsbury K.

Am J Psychiatry. 2007 Jul;164(7):1020-7. Review. No abstract available.

PMID:
17606652
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk